News Insmed Incorporated

Equities

INSM

US4576693075

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 01:30:00 11/03/2026 am IST			5-day change	1st Jan Change
143.85 ^USD	+0.50%		-1.69%	-17.35%

06:40pm	Insmed Incorporated Presents at Leerink Global Healthcare Conference 2026, Mar-10-2026 08:00 AM
02/03	Insmed Incorporated Presents at TD Cowen 46th Annual Health Care Conference, Mar-02-2026 09:50 AM

All News

06:40pm	Insmed Incorporated Presents at Leerink Global Healthcare Conference 2026, Mar-10-2026 08:00 AM
05/03	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	PR
02/03	Insmed Incorporated Presents at TD Cowen 46th Annual Health Care Conference, Mar-02-2026 09:50 AM
24/02	Insmed Insider Sold Shares Worth $1,615,257, According to a Recent SEC Filing	MT
23/02	Mizuho Securities Cuts Insmed Price Target to $204 From $211, Maintains Outperform Rating	MT
23/02	Insmed Gets UK Marketing Authorization for Non-Cystic Fibrosis Bronchiectasis Treatment	MT
23/02	MHRA says licensed brensocatib as first drug for non-cystic fibrosis bronchiectasis in patients aged 12+	RE
20/02	Insmed Q4 Reinforces Confidence in Brinsupri Growth, RBC Says	MT
20/02	Insmed May Top Revenue Target for Bronchiectasis Drug Brinsupri, Morgan Stanley Says	MT
20/02	Morgan Stanley Lifts Price Target on Insmed to $166 From $162, Keeps Equalweight Rating	MT
20/02	US Equity Indexes Fall as Trump Signals Timeline on Iran Diplomacy	MT
19/02	Insmed Incorporated, Q4 2025 Earnings Call, Feb 19, 2026
19/02	Insmed Incorporated Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
19/02	The Market's Nerves Are Showing
19/02	Insmed reports fourth-quarter and full-year 2025 financial results and provides business update	RE
19/02	Insmed Q4 Loss Widens, Revenue Rises	MT
19/02	Insmed: Q4 Earnings Snapshot	AQ
19/02	Earnings Flash (INSM) Insmed Incorporated Reports Q4 Revenue $263.8M, vs. FactSet Est of $237.8M	MT
19/02	Earnings Flash (INSM) Insmed Posts Q4 Loss $1.54 a Share, vs. FactSet Est of $1.02 Loss	MT
19/02	Insmed Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Business Update	PR
19/02	Insmed Incorporated Provides Earnings Guidance for the Full Year 2026	CI
13/02	Insmed To Present at March 2026 Investor Conferences	PR
12/02	Insmed Insider Sold Shares Worth $1,979,764, According to a Recent SEC Filing	MT
05/02	Insmed to Host Fourth-Quarter and Full-Year 2025 Financial Results Conference Call on Thursday, February 19, 2026	PR
28/01	Barclays Initiates Coverage on Insmed With Overweight Rating, $231 Price Target	MT